Predictors and outcomes of extracorporeal membrane oxygenation in COVID-19 patients with ARDS: A propensity-matched analysis of national inpatient sample
Recommended Citation
Ali S, Sattar Y, Erdem S, et al. Predictors and Outcomes of Extracorporeal Membrane Oxygenation in COVID-19 Patients With ARDS: A Propensity-Matched Analysis of National Inpatient Sample. Curr Probl Cardiol. 2023;48(11):101988. doi:10.1016/j.cpcardiol.2023.101988
Abstract
Extracorporeal membrane oxygenation (ECMO) is a significant treatment modality for COVID-19 patients on ventilators. The current data is limited for understanding the indicators and outcomes of ECMO in COVID-19 patients with acute respiratory distress syndrome (ARDS). The National Inpatient Sample (NIS) database from 2020 was queried in this study. Among 1,666,960 patients admitted with COVID-19, 99,785 (5.98%) patients developed ARDS, and 60,114 (60.2%) were placed on mechanical ventilation. Of these mechanically ventilated COVID-ARDS patients, 2,580 (4.3%) were placed on ECMO. Patients with ECMO intervention had higher adjusted odds (aOR) of blood loss anemia (aOR 9.1, 95% CI: 6.16 - 13.5, propensity score-matched (PSM) 42% vs. 5.4%, P
Document Type
Article
PubMed ID
37473942
Affiliations
Advocate Lutheran General Hospital